| Vikram Reddy Beemidi, | |
|
785 Ohio Ave, Suite 2h, Clarksdale, MS 38614-6217 | |
| (662) 627-3003 | |
| (662) 627-3014 |
| Full Name | Vikram Reddy Beemidi |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 21 Years |
| Location | 785 Ohio Ave, Clarksdale, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760654990 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 21908 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rcg Clarksdale | Clarksdale, MS | Dialysis facility |
| Baptist Memorial Hospital North Ms | Oxford, MS | Hospital |
| Northwest Mississippi Medical Center | Clarksdale, MS | Hospital |
| Greenwood Leflore Hospital | Greenwood, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology And Hypertension Associates Ltd | 1254327554 | 17 |
News Archive
Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.
StockPreacher.com announces an investment report featuring GenVec Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
After reviewing outcomes from thousands of cases, researchers at Johns Hopkins report that patients with blocked neck arteries who undergo carotid stenting to prop open the narrowed blood vessels fare decidedly worse if their surgeons re-inflate a tiny balloon in the vessel after the mesh stent is in place.
Baxter International Inc. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for extension of the therapeutic indications of KIOVIG to include a new indication for multifocal motor neuropathy (MMN), a severe, debilitating disorder requiring lifelong treatment.
› Verified 4 days ago
| Entity Name | Nephrology & Hypertension Associates Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902975139 PECOS PAC ID: 1254327554 Enrollment ID: O20040422000554 |
News Archive
Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.
StockPreacher.com announces an investment report featuring GenVec Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
After reviewing outcomes from thousands of cases, researchers at Johns Hopkins report that patients with blocked neck arteries who undergo carotid stenting to prop open the narrowed blood vessels fare decidedly worse if their surgeons re-inflate a tiny balloon in the vessel after the mesh stent is in place.
Baxter International Inc. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for extension of the therapeutic indications of KIOVIG to include a new indication for multifocal motor neuropathy (MMN), a severe, debilitating disorder requiring lifelong treatment.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vikram Reddy Beemidi, 785 Ohio Avenue, Suite 2h, Clarksdale, MS 38614-9130 Ph: (662) 627-3003 | Vikram Reddy Beemidi, 785 Ohio Ave, Suite 2h, Clarksdale, MS 38614-6217 Ph: (662) 627-3003 |
News Archive
Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.
StockPreacher.com announces an investment report featuring GenVec Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
After reviewing outcomes from thousands of cases, researchers at Johns Hopkins report that patients with blocked neck arteries who undergo carotid stenting to prop open the narrowed blood vessels fare decidedly worse if their surgeons re-inflate a tiny balloon in the vessel after the mesh stent is in place.
Baxter International Inc. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for extension of the therapeutic indications of KIOVIG to include a new indication for multifocal motor neuropathy (MMN), a severe, debilitating disorder requiring lifelong treatment.
› Verified 4 days ago
April Danielle Carter, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1970 Hospital Dr, Clarksdale, MS 38614 Phone: 337-842-7896 | |
Dr. Aman U Munir, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 785 Ohio Ave, Ste 2h, Clarksdale, MS 38614 Phone: 662-627-3003 Fax: 662-627-3095 | |
Dr. Kenneth W Kellough, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 705 N State St, Clarksdale, MS 38614 Phone: 662-621-2192 Fax: 662-621-2314 | |
Dr. Nikki Nikkia Cager, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 785 Ohio Ave Ste 2d, Clarksdale, MS 38614 Phone: 662-627-2509 Fax: 662-627-2420 | |
Dr. Richard E Brownstein, M.D. Nephrology Medicare: May Accept Medicare Assignments Practice Location: 785 Ohio Ave, Suite 3e, Clarksdale, MS 38614 Phone: 662-624-5801 Fax: 662-624-5804 | |
Mtanius A Sultani, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 581 Medical Dr, Clarksdale, MS 38614 Phone: 662-627-7163 Fax: 662-627-7150 |